Stock Updates

Today’s Top Gainers in the Market Teva Pharmaceutical Industries Limited (NYSE:TEVA) from Healthcare

Today’s top gainers include the company Teva Pharmaceutical Industries Limited (NYSE:TEVA) which is in the industry Drug Manufacturers – Other, gaining -0.36% today. In the last week its performance is 0.92%, and -2.18% for the past quarter. Currently, Teva Pharmaceutical Industries Limited, TEVA has a target price of 71.68, so today’s gain of -0.36% is a significant step towards its target price. The GAP today is therefore 0.27%.

Teva Pharmaceutical Industries Limited (NYSE:TEVA), has a market cap of 50581.89, and is based in Israel. Insider ownership is at 2.70%, and institutional ownership is 67.00%.

At the current price of 54.76, it has a dividend yield of 2.47%, and its target price is 71.68. This is with a profit margin of 8.70%, and total debt/equity of 0.34. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has a P/E of 28.61, as well as a forward P/E of 9.21.

With a current EPS of 1.92, and a forecasted EPS growth for next year at 12.90%,Teva Pharmaceutical Industries Limited (NYSE:TEVA) has had a EPS growth for the past five years at -13.10%. For the next five years EPS growth is projected to be 5.22%.

Performance for the year is -11.19%. Since its IPO date on 3/26/1990, the total performance to date is -15.20%.

Volume today for Teva Pharmaceutical Industries Limited (NYSE:TEVA), is 2164372, while its average volume is 6265.79. Whilst the total gain today was -0.36%, it did have a day high of -2.98%.

Volatility for this week has been at 1.80%, and 2.14% for the month. The 52-week low for Teva Pharmaceutical Industries Limited, TEVA has been 14.06%, while the 52-week-high has reached -22.48%.

Looking at its return of investments, which is 5.70%, and its return on assets is 3.30%. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has an operating margin of 19.30%. With a sales growth of -3.50% quarter over quarter. Bearing in mind that Teva Pharmaceutical Industries Limited, TEVA is in the sector Healthcare, its long-term debt/equity is 0.28, and has a current ratio of 1.3 and 1 for quick ratio.

So what is the value of Teva Pharmaceutical Industries Limited? Well its PEG is 5.48, and the P/S is 2.6, along with a P/B of 1.65. Meanwhile it has a p/cash of 8.48.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment